Entasis Therapeutics

-$0.00 (-0.23%) Today
-$0.00 (-0.23%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ETTX and other ETFs, options, and stocks.

About ETTX

Entasis Therapeutics Holdings, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery and development of novel antibacterial products for serious drug-resistant bacterial infections.

CEO
Manoussos Perros
Employees
51
Headquarters
Waltham, Massachusetts
Founded
2015

ETTX Key Statistics

Market cap
104.56M
Price-Earnings ratio
—
Dividend yield
—
Average volume
873.60K
High today
$2.19
Low today
$2.18
Open price
$2.18
Volume
116.70K
52 Week high
$3.88
52 Week low
$1.40

ETTX News

BenzingaMay 23

Innoviva Acquires AstraZeneca-Spin Off At $2.20/Share

Innoviva Inc (NASDAQ: INVA) has agreed to acquire Entasis Therapeutics Holdings Inc (NASDAQ: ETTX) at $2.20 per share in cash. Innoviva currently owns approxim
MarketWatchMay 23

Innoviva to Buy Rest of Entasis for $2.20 a Share in Cash - MarketWatch

By Michael Dabaie Innoviva Inc. agreed to acquire all the shares of late-stage clinical biopharmaceutical company Entasis Therapeutics Holdings Inc. it doesn't

ETTX Earnings

-$0.37
-$0.25
-$0.12
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure